Received Dec 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
pain; inability to walk; affected their nerves; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included Calcium gluconate, Chlorocresol, Dimeticone (Silicone). On an unknown date, the patient received Shingrix. On an unknown date, 1 day after receiving Shingrix, the patient experienced pain (Verbatim: pain), unable to walk (Verbatim: inability to walk) and nerve damage (Verbatim: affected their nerves). The patient was treated with ibuprofen and gabapentin. The outcome of the pain, unable to walk and nerve damage were not resolved. It was unknown if the reporter considered the pain, unable to walk and nerve damage to be related to Shingrix. It was unknown if the company considered the pain, unable to walk and nerve damage to be related to Shingrix. Additional Information: GSK Receipt Date: 22-DEC-2025 The patient self-reported this case for himself. The patient reported that that they received the Shingrix vaccine 4.5-5 months ago from reporting date (12/22) and started experiencing side effects the following day after receiving the vaccine. The patient stated that they have silicone injected into the butt, and the vaccine was also given in their butt, and they believe the injection has affected their nerves, and they have lost the ability to walk/ cannot hardly walk since receiving the vaccine. The patient was not taking any medications at the time of the vaccination. The batch number was not provided and a request for this information has been made.
Silicone